CMS changes mind on hospice drugs

Share this article:

The Centers for Medicaid & Medicare Services has revised guidance on authorization of hospice drugs for those under Medicare Advantage and Part D plans, according to a new memo.

The guidance memo, released July 18, says instead of having prior authorization for all hospice drugs, it will encourage PA requirements only on analgesics, antiemetics, laxatives and anti-anxiety drugs. These categories are common among terminally ill patients.

“This action by CMS will bring marked relief to hospice patients and their providers who have been dealing with the previous policy under which all drugs processed through Part D for hospice patients were subject to prior authorization,” said Andrea Devoti, National Association for Home Care & Hospice chairman of the board of directors.

The original requirement stemmed from concern that medications were being billed incorrectly to Part D plans. Hospices received a per-diem all-inclusive rate for a beneficiary. But hospice groups balked and said the new requirements would have forced terminally ill patients to fight between hospice providers and Part D plans, or give up on receiving medication.

Share this article:

More in News

Bulk of Medicaid to be managed care in two years: Avalere

Bulk of Medicaid to be managed care in ...

More than three-quarters of Medicaid beneficiaries will be enrolled in a managed care plan as of 2016, according to an Avalere Health analysis released Thursday. The numbers reveal that managed ...

Nursing home asked for employee's personal information too often, jury rules

The human resources department of a Maine nursing home did not properly protect a former employee's personal identification information, a jury recently ruled.

Test could confirm sepsis within an hour

Nursing home residents might benefit from a new way of diagnosing and treating sepsis made possible by discoveries out of the University of British Columbia.